Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)’s Director Alexander J. Denner acquired 850,000 shares of Ariad Pharmaceuticals stock on the open market in a transaction dated Aug. 15. The shares were purchased at an average price of $5.83 per share, for a total transaction of $4,955,500.00. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -3.46%. On last trading day company shares ended up $6.14. … Continue reading Trader’s Recap : Ariad Pharmaceuticals (NASDAQ:ARIA), Trulia (NYSE:TRLA), Hawkins (NASDAQ:HWKN), Compugen Ltd. (NASDAQ:CGEN), Oaktree Capital Group, LLC (NYSE:OAK)